South Asia's Largest Pharmaceutical Event in Mumbai

Informations

• Publié par: CPhI-India
• Nombre de lectures: 16
• Langue: English

Extrait

South Asia's Largest Pharmaceutical Event in Mumbai

PR Newswire MUMBAI, India, November 15, 2012

MUMBAI, India,November 15, 2012/PRNewswire/ --

The much awaited 3-day CPhI/P-MEC/ICSE/ BioPh exhibition for the pharmaceutical industry is all set to open in Mumbai onNovember 21, 2012. The exhibition will have participation of over 920 companies from all over the world, making it South Asia's largest pharmaceutical event. Visitor pre-registrations also show very encouraging numbers of attendees from over 90 countries interested in visiting CPhI/P-MEC/ICSE/ BioPh.

According to the India Business Equity Foundation, the Indian pharmaceutical market is set to double its exports to reachUS$500 billionby 2014, thereby attracting the attention of major global economies. Growing at a pace of 15% annually, it is no secret that Generics are the major strength of the Indian pharmaceutical sector. With a strong domestic market potential and the low-cost manufacturing advantage working in its favour, India is set to become increasingly prominent on the global pharmaceutical landscape in the near future.

Mr.Rajeev Kher, Additional Secretary, Department of Commerce, Ministry of Commerce and Industry, will be the Guest of Honour at the inaugural session to be held onNovember 21, 2012. The platform will provide an opportunity for attendees and exhibitors to interact and network with the industry players from the various segments within the field of pharmaceutical ingredients, machinery, equipment & technology, contract services and solutions. Onsite seminars will address various technology issues and the latest industry trends.

The CPhI India Awards will recognise and appreciate the contribution and efforts of the Indian pharmaceutical industry. There are seven broad categories identified for the awards. The categories include innovation in quality, product development, cost, the environment, Health & Safety (EHS), packaging and the lifetime achievem ent and Pharma Personality of the Year awards. The process advisors for the awards are Ernst & Young. Organised by UBM, the CPhI India Awards are supported by Pharmexcil and Brand India Pharma. The evaluation for the awards will be done by an independent panel of senior industry professionals. The award distribution event will be held on st 21 November, 2012.

CPhI India Awards 2012 will be an elite gathering of industry leaders who will meet, network and also attend a panel discussion on "Developing the Capability, Credibility and Culture to penetrate deeper into the global value chain for the Indian Pharma Industry".

About UBM India

UBM India is a part of UBM plc (http://www.ubm.com), a leading global business media company. We inform markets and bring the world's buyers and sellers together at events, online, and in print, providing them with the information they need to do business successfully. We organise leading industry trade exhibitions covering a wide range of verticals which include Pharmaceuticals, Security, Food Ingredients, Jewellery, IT, Nuclear Energy and Travel. With the confirmation of over 920 exhibitors and 26,000 attendees expected, CPhI India 2012 and its co- located events are the largest and most comprehensive pharmaceutical industry events in South Asia. Focused on pharmaceutical ingredients, machinery, equipment, research, outsourcing and bio-solutions for pharma, the event brings together high-quality prospects that are actively looking for these products and services.

Contact C. Bhaskar Senior Manager - Marketing Communications UBM India Pvt. Ltd Mumbai India T: [phone]/681 E:[e-mail]